Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat

Diabetes

Volumn 51, Issue 10, 2002, Pages 3055-3062

  Zagon, Ian S ^a,b   Jenkins, Joe B ^a   Sassani, Joseph W ^a   Wylie, James D ^a   Ruth, Torre B ^a   Fry, Jamie L ^a   Max Lang, C ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; NALTREXONE; OPIATE ANTAGONIST; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; DIABETES MELLITUS; DNA SYNTHESIS; DRUG EFFECT; ELECTRON MICROSCOPY; EPITHELIZATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; WOUND HEALING;

EID: 0036788361     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3055     Document Type: Article

References (49)

1. Feman SS: Diabetes and the eye. In Duane's Clinical Ophthalmology. Vol. 5. Tasman W, Ed. Philadelphia, PA, Lippincott Williams & Wilkins, 2000, p. 1-10
2. Herse PR: A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt 65:224-230, 1988
3. Sanchez-Thorin JC: The cornea in diabetes mellitus. Int Ophthalmol Clin 38:19-36, 1998
4. Friend J, Thoft RA: The diabetic cornea. Int Ophthalmol Clin 24:111-123, 1984
5. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH: Diabetic keratopathy. Trans Am Ophthalmol Soc 79:180-199, 1981
6. Taylor HR, Kimsey RA: Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci 20:548-553, 1981
7. Rosenberg ME, Tervo TMT, Immonen IJ, Muller LJ, Gronbagen-Riska C, Vesaluoma MH: Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 41:2915-2921, 2000
8. Saini JS, Khandalavla B: Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol 30:142-146, 1995
9. Ljubimov AV, Huang Z-S, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC: Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 46:1033-1041, 1998
10. Tabataby CA, Bumabacher M, Baumgartner B, Leuenberger PM: Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 24:111-123, 1988
11. Brightbill FS, Myers FL, Bresnick GH: Postvitrectomy keratopathy. Am J Ophthalmol 85:651-655, 1978
12. Perry HD, Foulks GN, Thoft RA, Tolentino FI: Corneal complications after closed vitrectomy through pars plana. Arch Ophthalmol 96:1401-1403, 1978
13. Foulks GN, Thoft RA, Perry MD, Toentino FI: Factors related to corneal epithelial complications after vitrectomy through the pars plana. Arch Ophthalmol 97:1076-1078, 1979
14. Nakamura M, Sato N, Chikama T-I, Hasegawa Y, Nishida T: Fibronectin facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res 64:355-359, 1997
15. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH: Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res 31:611-621, 1980
16. Friend J, Kiorpes TC, Thoft RA: Diabetes mellitus and the rabbit corneal epithelium. Invest Ophthalmol Vis Sci 21:317-321, 1981
17. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK: Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 110:537-540, 1992
18. Datiles MB, Kador PF, Fukui HN, Hu T-S, Konshita JH: Corneal reepithelialization in galactosenuc rats. Invest Ophthalmol Vis Sci 24:563-569, 1983
19. Hatchell DL, Magolan JJ, Besson MJ, Goldman AI, Pederson HJ, Schultz KJ: Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol 101:469-471, 1983
20. Zagon IS, Verderame MF, McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 38:351-376, 2002
21. Zagon IS, Sassani JW, McLaughlin PJ: Re-epithelialization of the rabbit cornea is regulated by opioid growth factor. Brain Res 803:61-68, 1998
22. Zagon IS, Sassani JW, McLaughlin PJ: Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors. Brain Res 798:254-260, 1998
23. Zagon IS, Verderame MF, Allen SS, McLaughlin PJ: Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans. Brain Res 856:75-83, 2000
24. Bisignani GJ, McLaughlin PJ, Ordille SD, Beltz MS, Jarowenko MV, Zagon IS: Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor. J Urol 162:2186-2191, 1999
25. Vermes I, Steinmetz E, Schoorl J, van der Veen EA, Tilders FJ: Increased plasma levels of immunoreactive beta-endorphin and corticotrophin in non-insulin-dependent diabetes. Lancet 2:725-726, 1985
26. Kolta MG, Pierzchala K, Houdi AA, Van Loon GR: Effect of diabetes on the levels of two forms of met-enkephalin in plasma and peripheral tissues of the rat. Neuropeptides 21:55-63, 1992
27. Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, Van Loon GR: Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides 30:335-344, 1996
28. Fallucca F, Tonnarini G, Di Biase N, D'Alessandro M, Negri M: Plasma met-enkephalin levels in diabetic patients: influence of autononuc neuropathy. Metabolism 45:1065-1068, 1996
29. Negri M, Tonnarini G, D'Alessandro M, Fallucca F: Plasma enkephalin in type I diabetes. Metabolism 41:460-461, 1992
30. Greenberg J, Ellyin F, Pullen G, Ehrenpreis S, Singh SP, Cheng J: Methionine-enkephalin and β-endorphin levels in brain, pancreas, and adrenals of db/db nuce. Endocrinology 116:328-331, 1985
31. Timmers K, Voyles NR, Zalenski C, Wilkins S, Recant L: Altered β-endorphin, met- and leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome. Diabetes 35:1143-1151, 1986
32. Pieper GM, Mizoguchi H, Ohsawa M, Kamei J, Nagase H, Tseng LF: Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse. Eur J Pharmacol 401:375-379, 2000
33. Grover VS, Sharma A, Singh M: Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice. Eur J Pharmacol 399:161-164, 2000
34. Berman Y, Devi L, Carr KD: Effects of streptozotocin-induced diabetes on prodynorphin-derived peptides in rat brain regions. Brain Res 685:129-134, 1995
35. Zagon IS, Sassani JW, McLaughlin PJ: Reepithelialization of the human cornea is regulated by endogenous opioids. Invest Ophthalmol Vis Sci 41:73-81, 2000
36. 5]-enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea. Brain Res 671:105-111, 1995
37. Mordes JP, Rossini AA: Animal models of diabetes. Am J Med 70:353-360, 1981
38. Arison RN, Ciaccio EI, Glitzer MS, Cassaro JA, Pruss MP: Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16:51-56, 1967
39. Zagon IS, Sassani JW, McLaughlin PJ: Cellular dynamics of corneal wound re-epithelialization in the rat. I. Fate of ocular surface epithelial cells synthesizing DNA prior to wounding. Brain Res 822:149-163, 1999
40. Zagon IS, Sassani JW, Kane ER, McLaughlin PJ: Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor. Brain Res 759:92-102, 1997
41. McDermott AM, Kern TS, Murphy CJ: The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells. Curr Eye Res 17:924-932, 1998
42. Hans DC, Isono M, Hoffman BB, Ziyadeh FN: High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 10:1891-1899, 1999
43. Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E: Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 50:1627-1635, 2001
44. Hehenberger K, Heilborn JD, Brismar K, Hansson A: Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of 1-lactate. Wound Repair Regen 6:135-141, 1998
45. Higuchi C, Sanaka T, Sato T, Omata M, Watanabe M, Mine S, Inuzuka N, Nihei H: The effect of glucose on the proliferation of peritoneal fibroblasts. Adv Perit Dial 13:253-256, 1997
46. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42:647-656, 1992
47. Snip RC, Thoft RA, Tolentino FI: Similar epithelial healing rates of the corneas of diabetic and nondiabetic patients. Am J Ophthalmol 90:463-468, 1980
48. Rosenberg CS: Wound healing in the patient with diabetes mellitus. Nurs Clin North Am 25:247-261, 1990
49. Kamal K, Powell RJ, Sumpio BE: The pathobiology of diabetes mellitus: implications for surgeons. J Am Coll Surg 183:271-289, 1996